Nuvation Bio Inc.

For the period ended Sep 30, 2025. Filed Nov 3, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 3, 2025

NUVB$4.35+4.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of New York, State of New York, on this 3rd day of November, 2025.

	NUVATION BIO INC.
Date: November 3, 2025	/s/ David Hung, M.D.
	David Hung, M.D.
	Founder, President and Chief Executive Officer
	Principal Executive Officer
Date: November 3, 2025	/s/ Philippe Sauvage
	Philippe Sauvage, Chief Financial Officer
	Principal Financial Officer

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.